COMMUNIQUÉS West-GlobeNewswire

IRADIMED CORPORATION Names Leslie McDonnell as President and Chief Executive Officer
29/07/2019
WINTER SPRINGS, Fla., July 29, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that its Board of Directors unanimously appointed Leslie McDonnell, to succeed Roger Susi as President and [...]
Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities
29/07/2019
Orphazyme A/S Company announcement No. 23/2019 Company Registration No. 32266355 Copenhagen, July 29, 2019 – Orphazyme A/S (ticker: ORPHA.CO), a biopharmaceutical company dedicated to developing treatments for patients [...]
NM Medical Cannabis Industry First Six Months Up 17% Over Last Year
29/07/2019
Ultra Health leads major economic development with $7.2 million capital expansion project ALBUQUERQUE, N.M., July 29, 2019 (GLOBE NEWSWIRE) -- Ultra Health, New Mexico’s #1 Cannabis Company, leads all 34 cannabis [...]
Test Release: 29.July
29/07/2019
This is a test release and can be ignored. The following is test content: Lorem ipsum dolor sit amet, consectetur adipiscing elit. Fusce semper convallis porta. Cras finibus tortor gravida vehicula vulputate. Donec [...]
ReFresh Aesthetic Center™ Relaunches CoolSculpting®
29/07/2019
Milwaukee Area’s Top Medical Aesthetic Center’s Team Kick Off the Summer with a Focus on Nonsurgical Fat-Reduction MILWAUKEE, Wis., July 29, 2019 (GLOBE NEWSWIRE) -- As one of the most popular body contouring treatments [...]
L’Agence européenne des médicaments accorde l’accès PRIME au Sepofarsen de ProQR pour l’amaurose congénitale de Leber 10
29/07/2019
Cet accès s'appuie sur une analyse intermédiaire positive des données cliniques et des données précliniques à ce jour La désignation PRIME fournit une voie pour des interactions fréquentes et précoces avec l'EMA visant [...]
Össur hf: Transactions in relation to share buyback program
29/07/2019
Announcement no. 45/2019 29 July 2019 Transactions in relation to share buyback program On 14 May 2019, Össur hf. initiated a share buy-back program, see Company announcement no. 31/2019. The purpose of the share [...]
Sanofi : Online Availability of Sanofi Group’s Half-Year Financial Report for 2019
29/07/2019
Online Availability of Sanofi Group’s Half-Year Financial Report for 2019 PARIS (France) – July 29, 2019 - Sanofi announces that its half-year financial report for the period ending June 30, 2019 is now available and [...]
Sanofi : Mise en ligne du rapport financier semestriel 2019
29/07/2019
Mise en ligne du rapport financier semestriel 2019 PARIS (France) – 29 juillet 2019 - Sanofi annonce aujourd’hui avoir mis à la disposition du public et déposé auprès de l’Autorité des marchés financiers (AMF) son [...]
Valneva Announces Formation of Scientific Advisory Board
29/07/2019
Valneva Announces Formation of Scientific Advisory Board Saint Herblain (France), July 29, 2019 – Valneva SE (“Valneva” or “the Company”), a biotech company developing and commercializing vaccines for infectious [...]
Valneva annonce la création de son Conseil Scientifique
29/07/2019
Valneva annonce la création de son Conseil Scientifique Saint Herblain (France), 29 juillet 2019 – Valneva SE (“Valneva” ou “le Groupe”), société de biotechnologie développant et commercialisant des vaccins contre des [...]
Spineway : Arrangements for availability of the preparatory documents for the General Shareholders’ Meeting of 16 August 2019
29/07/2019
Arrangements for availability of the preparatory documents for the General Shareholders’ Meeting of 16 August 2019 Arrangements for making preparatory documents available The shareholders of Spineway are invited to [...]
SPINEWAY : Convocation Assemblée Générale Mixte des Actionnaires 16 août 2019
29/07/2019
Convocation Assemblée Générale Mixte des Actionnaires Spineway le 16 août 2019 Modalités de mise à disposition des documents préparatoires Spineway informe ses actionnaires qu’ils sont convoqués en Assemblée Générale [...]
New phantom share-based incentive program
29/07/2019
Orphazyme A/S Company announcement No. 22/2019 Company Registration No. 32266355 Copenhagen, July 29, 2019 – Orphazyme A/S (ticker: ORPHA.CO), a biopharmaceutical company dedicated to developing treatments for patients [...]
New share-based incentive program
29/07/2019
Orphazyme A/S Company announcement No. 21/2019 Company Registration No. 32266355 Copenhagen, Denmark, July 29, 2019 – Orphazyme A/S (ticker: ORPHA.CO), a biopharmaceutical company dedicated to developing treatments for [...]
New incentive program for the Board of Directors of Orphazyme
29/07/2019
Orphazyme A/S Company announcement No. 20/2019 Company Registration No. 32266355 Copenhagen, Denmark, July 29, 2019 – Orphazyme A/S (the “Company”), a biopharmaceutical company dedicated to developing treatments for [...]
IBRI announces research team for its Diabetes Center
29/07/2019
INDIANAPOLIS, July 29, 2019 (GLOBE NEWSWIRE) -- The Indiana Biosciences Research Institute (IBRI) today announced new investigators for the IBRI Diabetes Center (IDC) . At its first diabetes seminar, held today at Lilly [...]
Healthwise Announces Christy Calhoun as Chief Content Solutions Officer
29/07/2019
BOISE, Idaho, July 29, 2019 (GLOBE NEWSWIRE) -- Healthwise, a leader in evidence-based health education, technology, and services, announced today that Christy Calhoun, MPH, has been named chief content solutions [...]
Golden Leaf Holdings Announces Extension of Chalice Earn-Out Payment
29/07/2019
TORONTO, July 29, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a pioneer cannabis company built around recognized brands for the wellness and recreational markets [...]

Pages